[Ultrasound-guided percutaneous injection of alcohol. Is it an elective therapy in small diameter nodular hepatocarcinoma associated with cirrhosis?].
The authors discuss percutaneous alcohol injection as elective therapy for small hepatocellular carcinoma (less than 5 cm) in liver cirrhosis. Thirteen patients were classified as Child C cirrhosis. Thirty-six months actuarial survival is 60%. These results are similar in patients selected for surgical resection.
Salmi
A
A
D000279:Administration, Cutaneous; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D014463:Ultrasonography
D000431:Ethanol
Alcolizzazione percutanea ecoguidata. Terapia elettiva per l'epatocarcinoma nodulare di piccolo diametro associato alla cirrosi?